Zouina Sarfraz, Postdoctoral Research Fellow in Oncology at the Miami Cancer Institute, shared a post on X:
“Honored to receive the GRASP Advocate Choice Award at ASCO 2026 for our poster, ‘Who Gets Access? National Discrepancies in Clinical Trial Enrollment Among Patients With Brain Metastases.’
What makes this recognition especially meaningful is that it comes directly from patient advocates. GRASP, a patient-led organization founded by cancer survivors, recognizes research with the potential to make a meaningful difference for patients and families facing cancer. Grateful to my biggest supporter and mentor, Dr Ahluwalia (Manmeet Ahluwalia)!
Thank you to my co-authors Manuela, Fatma Nihan Akkoc Mustafayev, Azza Sarfraz, Khalid Qidwai, Ruchit Jain, Namita, Ruchit, Lydia and the team at Herbert Wertheim Cancer Institute (formerly Miami Cancer Institute, Herbert Wertheim Cancer Institute Research, Baptist Health) for their support and commitment to advancing care for patients with CNS disease.”
Title: Who gets access? National discrepancies in clinical trial enrollment among patients with brain metastases.
Authors: Manuela Jaramillo, Zouina Sarfraz, Fatma Nihan Akkoc Mustafayev, Azza Sarfraz, Khalid Ahmad Qidwai, Namita Ruhela, Ruchit Jain, Lydia Hodgson, and Manmeet Singh Ahluwalia
Other articles featuring Zouina Sarfraz on OncoDaily.
